ID
42142
Description
A Study of ARQ 197 in Combination With Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT01251796
Link
https://clinicaltrials.gov/show/NCT01251796
Keywords
Versions (2)
- 5/29/16 5/29/16 -
- 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
Uploaded on
April 13, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
egfr-tki
Data type
boolean
Description
cancer surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C0920424
Description
Multiple malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0346429
Description
brain metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
intercurrent illness
Data type
boolean
Alias
- UMLS CUI [1]
- C3640977
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
contraceptive measures
Data type
boolean
Alias
- UMLS CUI [1]
- C0700589
Similar models
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
- StudyEvent: Eligibility
C1443775 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])